Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss
Well, research suggests that adipose tissue (body fat) produces hormones, including estrogen, that may directly influence the uterine lining and contribute to heavier menstrual bleeding in people with higher BMIs
What's in the other ~2.7%
If you have missed a dose of semaglutide (Ozempic and Wegovy) or tirzepatide (Mounjaro and Zepbound), take it within 5 days of the missed dose
Injection technique and administration Proper injection technique reduces the incidence of local side effects
This phenomenon, also known as a paradoxical early worsening of DR, has been described in insulin users since the 1980s
